Biomarkers predictive of PD1/PD-L1 immunotheraphy in non-small cell lung cancer

Lupo, A; Alifano, M; Wislez, M; Boulle, G; Velut, Y; Biton, J; Cremer, I; Goldwasser, F; Leroy, K; Damotte, D

Damotte, D (reprint author), Univ Paris 05, Hop Univ Paris Ctr Site Cochin, AP HP, Serv Pathol, 27 Rue Faubourg St Jacques, F-75014 Paris, France.

REVUE DE PNEUMOLOGIE CLINIQUE, 2018; 74 (5): 339

Abstract

Immune checkpoint inhibitors (ICI), targeting the PD1/PD-L1 axis has shown their efficacy in lung cancer but only in a restricted population of patien......

Full Text Link